Beyond the Chart: Exploring the AI Frontier for Oncology

DeepScribe

Beyond the Chart examines the current state of cancer care delivery and AI technology's role in oncology centers today and in a promising future. Each episode features detailed conversations with oncology leaders and clinicians, health tech innovators, and entrepreneurs driving change at the intersection of AI and oncology. Learn how intelligent tools transform clinical workflows, decision-making, and the patient experience.  Tune in for out-of-the-box thinking, real-world outcomes, and a front-row seat to the future of oncology.

  1. 1d ago

    How New Cancer Treatments Become Reality with Dr. Boris Pasche

    What does it take to change the way cancer is treated? In this episode, we’re joined by Dr. Boris Pasche, President and CEO of Karmanos Cancer Institute and Chair of Oncology at Wayne State University School of Medicine. Dr. Pasche discovered a foundational cancer gene early in his career before spending nearly two decades developing TheraBionic, a novel cancer treatment authorized by the FDA in 2023. We explore the personal experience that drove Dr. Pasche to pursue a different approach to cancer treatment, the perseverance required to make a new therapy reality, and what really matters when you're challenging the status quo. We also dive deep into where AI is delivering meaningful value across oncology today. If you're interested in how breakthrough ideas become real treatments, this conversation offers an inside look at how innovation can shape the future of oncology. Covered in this episode: Why Dr. Boris Pasche spent two decades developing a breakthrough new cancer therapy.What it takes to bring an innovation through FDA approval.The balance between certainty and moving innovation forward.Where AI is already creating value in oncology.What it means to be first in cancer innovation. If you got value from this episode of Beyond the Chart, subscribe on your favorite podcast platform so you don’t miss the next one. LEARN MORE Karmanos - https://www.karmanos.org/ DeepScribe - https://www.deepscribe.ai/ CONNECT Dr. Boris Pasche on LinkedIn - https://www.linkedin.com/in/boris-pasche-83b55715/ Matthew Ko on LinkedIn - https://www.linkedin.com/in/komatthew/ LISTEN Spotify - https://open.spotify.com/show/6IQlU4UeNKLLM4Y1lPTaOV?si=33679e9eb2294adf Apple Podcasts - https://podcasts.apple.com/us/podcast/beyond-the-chart-exploring-the-ai-frontier-for-oncology/id1832485207 YouTube - https://www.youtube.com/@deepscribeinc.5623

    How New Cancer Treatments Become Reality with Dr. Boris Pasche
  2. Aug 12

    The Real Reasons Why Some Physicians Don’t Trust AI with Dr. Kimberly Ku (Part 2)

    Why do some physicians embrace AI while others still resist it? In this episode, we speak with Dr. Kimberly Ku - medical oncologist, researcher, advocate for value-based care, podcast host, and film producer. In this second part of our conversation, we shift from patient communication to one of healthcare's biggest challenges today: AI adoption. Dr. Ku draws on lessons from tactical empathy and negotiation to explain why resistance to AI is often rooted in fear rather than the technology itself. We explore what it really takes to earn clinicians' trust, why community practices will play a huge role in determining AI's future, and how thoughtful implementation can reduce the administrative burden for clinicians while potentially improving outcomes. If you’re on the fence when it comes to AI adoption in healthcare, or you simply want to know more about where the narrative around AI in oncology stands today, this is for you. Covered in this episode: Where AI adoption in healthcare stands today.Why community practices are shaping the future of AI.The biggest barriers preventing clinicians from adopting new technology.How to reframe resistance to AI through trust and communication.The skills physicians will need in an AI future. If you got value from this episode of Beyond the Chart, subscribe on your favorite podcast platform so you don’t miss the next one. LEARN MORE Val-You Based Care podcast - https://val-you-based-care.captivate.fm/ DeepScribe - https://www.deepscribe.ai/ CONNECT Matthew Ko on LinkedIn - https://www.linkedin.com/in/komatthew/ LISTEN Spotify - https://open.spotify.com/show/6IQlU4UeNKLLM4Y1lPTaOV?si=33679e9eb2294adf Apple Podcasts - https://podcasts.apple.com/us/podcast/beyond-the-chart-exploring-the-ai-frontier-for-oncology/id1832485207 YouTube - https://www.youtube.com/@deepscribeinc.5623

    The Real Reasons Why Some Physicians Don’t Trust AI with Dr. Kimberly Ku (Part 2)
  3. Jul 29

    What Hostage Negotiation Tactics Can Teach Us About Bedside Manner with Dr. Kimberly Ku (Part 1)

    What could hostage negotiations teach oncologists about patient care? In this episode, we’re joined by Dr. Kimberly Ku - medical oncologist, researcher, advocate for value-based care, podcast host, and film producer. After years of following a more traditional pathway, Kim began questioning whether medicine was truly helping clinicians connect with the patient sitting in front of them. That led her outside healthcare and to the work of former FBI hostage negotiator Chris Voss. We explore how Dr. Ku has adapted Chris’ principles of tactical empathy to patient care, and why the words clinicians choose (and even the ones they don’t say outloud) can shape trust and understanding within some of the most difficult conversations in oncology. If you're looking to strengthen patient relationships and navigate difficult conversations with confidence and empathy, this episode offers techniques you can start using today. Covered in this episode: How to use tactical empathy to strengthen patient relationships.Three practical communication techniques clinicians can use today.Why Dr. Ku looked beyond medicine to improve patient communication.A different approach to delivering difficult news with compassion.What to avoid saying during challenging conversations. If you got value from this episode of Beyond the Chart, subscribe on your favorite podcast platform so you don’t miss the next one. LEARN MORE Val-You Based Care podcast - https://val-you-based-care.captivate.fm/ DeepScribe - https://www.deepscribe.ai/ CONNECT Matthew Ko on LinkedIn - https://www.linkedin.com/in/komatthew/ LISTEN Spotify - https://open.spotify.com/show/6IQlU4UeNKLLM4Y1lPTaOV?si=33679e9eb2294adf Apple Podcasts - https://podcasts.apple.com/us/podcast/beyond-the-chart-exploring-the-ai-frontier-for-oncology/id1832485207 YouTube - https://www.youtube.com/@deepscribeinc.5623

    What Hostage Negotiation Tactics Can Teach Us About Bedside Manner with Dr. Kimberly Ku (Part 1)
  4. Jul 15

    The Missing Data That Could Change Oncology with Dr. Caroline Chung

    Until now, our understanding of oncology has largely been built on universal standards. But what if those standards only tell part of the story? In this episode, we’re joined by Dr. Caroline Chung, Co-Director of the Institute for Data Science in Oncology. Caroline leads one of the world's largest cancer data infrastructures while continuing to care for patients, giving her a unique perspective on how data, AI, and clinical practice intersect. We explore what led her from the clinic into building data infrastructure, why she became passionate about metadata long before AI was on most people’s radar, and how advances in unstructured data are changing what's possible. We also discuss ambient documentation and the clinical details that are often lost during patient conversations, and why capturing those missing pieces could fundamentally change cancer research and care. If you're interested in the future of AI, data, and decision-making in oncology, this conversation explores how capturing the right information may be just as important as how we analyze it. Covered in this episode: What led Dr. Caroline Chung to build the data infrastructure for one of the largest cancer centers in the world. The evolving role of metadata in the age of AI.Choosing the right metrics for different use cases.Why some AI implementations succeed while others struggle.What may be getting lost during conversations between clinicians and patients. If you got value from this episode of Beyond the Chart, subscribe on your favorite podcast platform so you don’t miss the next one. LEARN MORE DeepScribe - https://www.deepscribe.ai/ CONNECT Dr. Caroline Chung on LinkedIn - https://www.linkedin.com/in/chung-caroline/ Matthew Ko on LinkedIn - https://www.linkedin.com/in/komatthew/ LISTEN Spotify - https://open.spotify.com/show/6IQlU4UeNKLLM4Y1lPTaOV?si=33679e9eb2294adf Apple Podcasts - https://podcasts.apple.com/us/podcast/beyond-the-chart-exploring-the-ai-frontier-for-oncology/id1832485207 YouTube - https://www.youtube.com/@deepscribeinc.5623

    The Missing Data That Could Change Oncology with Dr. Caroline Chung
  5. Jul 1

    The Hidden Barriers to Progress Within Oncology with Dr. Adam Bass

    How do you know when following the guidelines is the right call… and when it isn't? That question becomes very real when you're sitting across from a patient whose situation doesn't fit neatly into the evidence. In this episode, we’re joined by Dr. Adam Bass, physician-scientist and incoming leader of the Gastroesophageal Cancer Therapeutics Accelerator at Memorial Sloan Kettering. Dr. Bass has spent his career tackling some of oncology's most complex questions. His work with The Cancer Genome Atlas helped reveal that what was once thought to be a single disease was actually several distinct diseases with different underlying biologies, a discovery that continues to influence drug development today. He later led global oncology drug development at Novartis before returning to patient care and research. In this conversation, we explore the tension between evidence and individual patients, why more data doesn't always make decisions easier, and whether some of the biggest challenges in oncology stem from the disease itself or how we've chosen to study it. We also discuss clinical trial design, patient education, the future role of the oncologist, and why collaboration may be one of the most important drivers of progress. This episode offers a thoughtful look at some of the hardest questions in modern oncology. Covered in this episode: When it's right to follow the guidelines and when it may not be.Why more data doesn't always lead to clearer decisions.The gap in patient understanding and education.Why trying to understand everything about AI could be blocking us from solving bigger problems.The power of collaboration in solving oncology's toughest problems If you got value from this episode of Beyond the Chart, subscribe on your favorite podcast platform so you don’t miss the next one. LEARN MORE DeepScribe - https://www.deepscribe.ai/ CONNECT Adam Bass on LinkedIn - https://www.linkedin.com/in/adam-bass-a1402534 Matthew Ko on LinkedIn - https://www.linkedin.com/in/komatthew/ LISTEN Spotify - https://open.spotify.com/show/6IQlU4UeNKLLM4Y1lPTaOV?si=33679e9eb2294adf Apple Podcasts - https://podcasts.apple.com/us/podcast/beyond-the-chart-exploring-the-ai-frontier-for-oncology/id1832485207 YouTube - https://www.youtube.com/@deepscribeinc.5623

    The Hidden Barriers to Progress Within Oncology with Dr. Adam Bass
  6. Jun 17

    How Do You Build Technology Oncologists Actually Trust? with Lavi Kwiatkowsky

    How do you build something oncology practices will actually use and trust? In this episode, I’m joined by Lavi Kwiatkowsky, Founder and CEO of Canopy, an AI platform built specifically for the care that happens between oncology visits. Think remote patient monitoring, AI-powered call management, and the infrastructure needed to support patients when they’re not sitting in front of a clinician. Unlike many of our guests, Lavi isn’t a physician. He’s a fellow founder. We’ve both spent close to a decade building in oncology, drawn to the space by personal healthcare experiences and a belief that some of healthcare’s most important problems can be solved through better systems and technology. We explore the experience that led Lavi to start Canopy, the process failures he encountered as a patient, and why trust remains the biggest hurdle facing technological innovations in oncology. This conversation offers a practical look at what it takes to drive meaningful change in oncology. Covered in this episode: Why trust is the biggest challenge in healthcare technology adoption.What turns skeptical clinicians into technology advocates.The areas of oncology most ready for AI and automation.What an oncology-specific technology stack could look like.How change management influences technology adoption. If you got value from this episode of Beyond the Chart, subscribe on your favorite podcast platform so you don’t miss the next one. LEARN MORE Canopy - https://canopycare.us/ DeepScribe - https://www.deepscribe.ai/ CONNECT Lavi Kwiatkowsky - https://www.linkedin.com/in/lavi-kwiatkowsky-87016222 Matthew Ko on LinkedIn - https://www.linkedin.com/in/komatthew/ LISTEN Spotify - https://open.spotify.com/show/6IQlU4UeNKLLM4Y1lPTaOV?si=33679e9eb2294adf Apple Podcasts - https://podcasts.apple.com/us/podcast/beyond-the-chart-exploring-the-ai-frontier-for-oncology/id1832485207 YouTube - https://www.youtube.com/@deepscribeinc.5623

    How Do You Build Technology Oncologists Actually Trust? with Lavi Kwiatkowsky
  7. Jun 3

    Expert Insights on the Patient Experience in Oncology

    Technology in oncology is not just about efficiency or innovation. At its best, it creates more space for human connection, deeper understanding, and better care for the people behind the diagnosis. Today on Beyond the Chart, we look back at some of the most impactful conversations we’ve had on the podcast through one lens - the patient. We’re revisiting perspectives from leaders across the oncology world on what it means to care for the whole patient, how the challenges facing clinicians have evolved, and where technology may help strengthen the relationship between patients and providers rather than weaken it. We hear from Dr. Kathy Oubre on caring for patients within her Louisiana community, Dr. Diane Reidy-Lagunes on human connection and physician burnout, Dr. Guri Doshi on bridging the gap between caregivers and patients, and Dr. Douglas Flora on how AI may help make care more human. We also revisit conversations with Dr. Lalan Wilfong on caring for patients between visits, Dr. Debra Patt on patient education and clinical knowledge at the point of care, Dr. Sean Khozin on the importance of communication and human signals in medicine, Dr. Sanjay Juneja on patient access, and Dr. Lidia Schapira on survivorship care and the future role of AI in oncology. If you care about the human side of cancer care, this episode brings together some of the most thoughtful perspectives shared on Beyond the Chart so far. Covered in this episode: How technology can support more human-centered cancer care.The evolving challenges clinicians face in serving patients.Why communication remains central to oncology.How AI may help strengthen the physician-patient relationship. If you got value from this episode of Beyond the Chart, subscribe on your favorite podcast platform so you don’t miss the next one. LEARN MORE DeepScribe - https://www.deepscribe.ai/ CONNECT Matthew Ko on LinkedIn - https://www.linkedin.com/in/komatthew/ LISTEN Spotify - https://open.spotify.com/show/6IQlU4UeNKLLM4Y1lPTaOV?si=33679e9eb2294adf Apple Podcasts - https://podcasts.apple.com/us/podcast/beyond-the-chart-exploring-the-ai-frontier-for-oncology/id1832485207 YouTube - https://www.youtube.com/@deepscribeinc.5623

    Expert Insights on the Patient Experience in Oncology
  8. May 13

    AI Adoption in Oncology: Two Different Perspectives with the Oncology Brothers

    In oncology, there are 40 to 50 new drug approvals and indications every year. How is any oncologist supposed to keep up with that and still see patients? In this episode, we’re joined by the Oncology Brothers - Dr. Rohit Gosain and Dr. Rahul Gosain. Rohit is an oncologist at Roswell Park Comprehensive Cancer Center with a background in computer engineering, and Rahul practices at the Wilmot Cancer Institute and holds an MBA alongside his MD. Together, they’ve built one of the most followed oncology podcasts in the U.S., helping clinicians make sense of the latest research in. We explore how their podcast came to be, and the value that it’s bringing to the community. We then dive deep into AI adoption. Rohit is already using ambient AI in his practice, while Rahul, by his own admission, is not, leading to a balanced discussion on what it will take to bring more oncologists on board. Covered in this episode: How oncologists can keep up with rapid change.How the OncBrothers built one of the most followed oncology podcasts.Two different perspectives on AI adoption in oncology.What’s holding clinicians back from using AI tools?Where AI is already adding value in oncology practice. If you got value from this episode of Beyond the Chart, subscribe on your favorite podcast platform so you don’t miss the next one. LEARN MORE OncBrothers on YouTube - https://www.youtube.com/@oncologybrothers DeepScribe - https://www.deepscribe.ai/ CONNECT Dr. Rahul Gosain on LinkedIn - https://www.linkedin.com/in/gosainrahul Dr. Rohit Gosain on LinkedIn - https://www.linkedin.com/in/rohit-gosain Matthew Ko on LinkedIn - https://www.linkedin.com/in/komatthew/ LISTEN Spotify - https://open.spotify.com/show/6IQlU4UeNKLLM4Y1lPTaOV?si=33679e9eb2294adf Apple Podcasts - https://podcasts.apple.com/us/podcast/beyond-the-chart-exploring-the-ai-frontier-for-oncology/id1832485207 YouTube - https://www.youtube.com/@deepscribeinc.5623

    AI Adoption in Oncology: Two Different Perspectives with the Oncology Brothers

Ratings & Reviews

5
out of 5
12 Ratings

About

Beyond the Chart examines the current state of cancer care delivery and AI technology's role in oncology centers today and in a promising future. Each episode features detailed conversations with oncology leaders and clinicians, health tech innovators, and entrepreneurs driving change at the intersection of AI and oncology. Learn how intelligent tools transform clinical workflows, decision-making, and the patient experience.  Tune in for out-of-the-box thinking, real-world outcomes, and a front-row seat to the future of oncology.

You Might Also Like